Hypoglycemia as first presentation of presumed immune checkpoint inhibitor‐induced type 1 diabetes

We present a case of a 60‐year‐old male diagnosed with metastatic clear cell renal cell carcinoma who developed hypoglycemia during induction ipilimumab and nivolumab treatment. This was diagnosed as presumed type 1 diabetes mellitus secondary to immunotherapy.

Detalles Bibliográficos
Autores principales: Kamal, Rayyan Syed, Dean, Arleigh, Dutt, Hanna, Rajeh, Adnan, Fernandes, Ricardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485243/
https://www.ncbi.nlm.nih.gov/pubmed/37692147
http://dx.doi.org/10.1002/ccr3.7897
_version_ 1785102741518942208
author Kamal, Rayyan Syed
Dean, Arleigh
Dutt, Hanna
Rajeh, Adnan
Fernandes, Ricardo
author_facet Kamal, Rayyan Syed
Dean, Arleigh
Dutt, Hanna
Rajeh, Adnan
Fernandes, Ricardo
author_sort Kamal, Rayyan Syed
collection PubMed
description We present a case of a 60‐year‐old male diagnosed with metastatic clear cell renal cell carcinoma who developed hypoglycemia during induction ipilimumab and nivolumab treatment. This was diagnosed as presumed type 1 diabetes mellitus secondary to immunotherapy.
format Online
Article
Text
id pubmed-10485243
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-104852432023-09-09 Hypoglycemia as first presentation of presumed immune checkpoint inhibitor‐induced type 1 diabetes Kamal, Rayyan Syed Dean, Arleigh Dutt, Hanna Rajeh, Adnan Fernandes, Ricardo Clin Case Rep Case Report We present a case of a 60‐year‐old male diagnosed with metastatic clear cell renal cell carcinoma who developed hypoglycemia during induction ipilimumab and nivolumab treatment. This was diagnosed as presumed type 1 diabetes mellitus secondary to immunotherapy. John Wiley and Sons Inc. 2023-09-07 /pmc/articles/PMC10485243/ /pubmed/37692147 http://dx.doi.org/10.1002/ccr3.7897 Text en © 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Report
Kamal, Rayyan Syed
Dean, Arleigh
Dutt, Hanna
Rajeh, Adnan
Fernandes, Ricardo
Hypoglycemia as first presentation of presumed immune checkpoint inhibitor‐induced type 1 diabetes
title Hypoglycemia as first presentation of presumed immune checkpoint inhibitor‐induced type 1 diabetes
title_full Hypoglycemia as first presentation of presumed immune checkpoint inhibitor‐induced type 1 diabetes
title_fullStr Hypoglycemia as first presentation of presumed immune checkpoint inhibitor‐induced type 1 diabetes
title_full_unstemmed Hypoglycemia as first presentation of presumed immune checkpoint inhibitor‐induced type 1 diabetes
title_short Hypoglycemia as first presentation of presumed immune checkpoint inhibitor‐induced type 1 diabetes
title_sort hypoglycemia as first presentation of presumed immune checkpoint inhibitor‐induced type 1 diabetes
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485243/
https://www.ncbi.nlm.nih.gov/pubmed/37692147
http://dx.doi.org/10.1002/ccr3.7897
work_keys_str_mv AT kamalrayyansyed hypoglycemiaasfirstpresentationofpresumedimmunecheckpointinhibitorinducedtype1diabetes
AT deanarleigh hypoglycemiaasfirstpresentationofpresumedimmunecheckpointinhibitorinducedtype1diabetes
AT dutthanna hypoglycemiaasfirstpresentationofpresumedimmunecheckpointinhibitorinducedtype1diabetes
AT rajehadnan hypoglycemiaasfirstpresentationofpresumedimmunecheckpointinhibitorinducedtype1diabetes
AT fernandesricardo hypoglycemiaasfirstpresentationofpresumedimmunecheckpointinhibitorinducedtype1diabetes

Ejemplares similares